Terms ending in 2031
Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,512,983 | Production of Proteins in Glutamine-Free Cell Culture Media In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 9,200,071 | Methods of Treating Cancer Using NOTCH1 and NOTCH3 Antagonists In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 8,404,239 | ANTI-NOTCH2 NRR Antibodies In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 8,541,178 | Analysis of Antibody Drug Conjugates by Bead-Based Affinity Capture and Mass Spectrometry In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 9,822,400 | Methods for Treating, Diagnosing, and Monitoring Rheumatoid Arthritis In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 8,183,347 | ANTI-TAT226 Antibodies and Immunoconjugates In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 9,662,395 | Compositions and Methods Useful for Stabilizing Protein-Containing Formulations In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 9,556,267 | ANTI-LRP6 Antibodies In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 8,969,051 | Process for Producing Optically Active 2-Alkyl-1,1,3-Trialkoxycarbonylpropane In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 9,556,262 | Anti-Polyubiquitin Antibodies and Methods of Use In force · High confidence | Genentech, Inc. | In force | High confidence | |
| 59 more term ends in 2031 · Pro | |||||
10 of 69 patents shown. Soonest term end first, then patent number.
Pro members see all 69.
45 of these are in force and held by Genentech, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.